9
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Emergence of carbapenem-resistant Acinetobacter in a temperate north Indian State

, , , , &
Pages 156-160 | Accepted 25 Oct 2013, Published online: 20 Jan 2016
 

Abstract

This study aims to determine drug sensitivity, metallo-β-lactamase (MBL) production and elaboration of blaOXA-type carbapenemases in Acinetobacter spp. in a temperate climate area in north India with a heavy influx of tourists. Antimicrobial sensitivity of 165 isolates was performed. Imipenem-resistant isolates were subjected to combined disk (CDT) and double-disk diffusion tests (DDT) for MBL detection. Minimum inhibitory concentration (MIC) and MBL production were tested by Etest. A multiplex polymerase chain reaction (PCR) was performed for the detection of genes encoding blaOXA-23 like, blaOXA-24 like, blaOXA-51 like and blaOXA-58 like genes. Ninety-nine (60%) isolates were imipenem-resistant (MICs 2–96 μg/mL). Fifty (50.5%) of the 99 carbapenem-resistant isolates were MBL producers by CDT and 26 (26.3%) by DDT. The majority (77%) of the isolates elaborated blaOXA-23 and blaOXA-51 like genes. Forty seven of the 50 MBL-positive isolates harboured blaOXA-23 like and blaOXA-51 like genes. MBL-producing Acinetobacter has emerged as a major pathogen in Kashmir with elaboration of blaOXA-23 and blaOXA-51 related carbapenemases. This poses a significant challenge for healthcare professionals and policy planners, and needs to be addressed immediately. Primary care physicians treating visitors to Kashmir need to be aware of the situation.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.